Autoimmune hepatitis - 2013 Lancet review

In common with many autoimmune diseases, autoimmune hepatitis is associated with non-organ-specific antibodies in the context of hepatic autoimmunity.

Autoimmune hepatitis can present in acute or chronic forms.

Remission is achievable in up to 85% of cases. For the remaining patients, immunosuppression is an option.

Liver transplantation provides an excellent outcome for patients with acute liver failure or complications of end-stage liver disease, including hepatocellular carcinoma.

References:

Autoimmune hepatitis: The Lancet http://bit.ly/1aApnxp